$OABI News
Last published 1w ago
- 1w agoOABIOmniAb, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoOABIOmniAb Reports Third Quarter 2026 Financial Results and Business HighlightsBusiness WireRaises Full Year 2026 Revenue and Cash Outlook on Continued Business Momentum Conference Call to Begin Today at 8:00 a.m. ET OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to
- 2w agoOABIOmniAb to Participate in Upcoming Investor Conferences in NovemberBusiness WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced management’s participation in the following upcoming
- 4w agoOABIOmniAb to Report Third Quarter 2026 Financial Results on October 30Business WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and
- 1mo agoOABIOmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst DayBusiness WireFormal presentation begins today, October 6, 2026, at 11 a.m. ET OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today
- 1mo agoOABIOmniAb to Host Investor & Analyst Day on October 6, 2026Business WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reiterates details of its upcoming Investor & Analyst Day, to be
- 2mo agoOABIOmniAb to Participate in Upcoming Investor ConferencesBusiness WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced management’s participation in the following upcoming
- 2mo agoOABIOmniAb Raises 2026 Financial GuidanceBusiness WireIncreases Full Year 2026 Cash Outlook Following Recent Technology Licensing Activity OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation
- 2mo agoOABIOmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & CompanyBusiness WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced a global collaboration and license agreement with Eli Lilly
- 3mo agoOABIOmniAb Reports Second Quarter 2026 Financial Results and Business HighlightsBusiness WireRaises Full Year 2026 Revenue and Cash Outlook Driven by Continued Business Momentum Conference Call to Begin Today at 4:30 p.m. ET OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research
- 3mo agoVRXAOABIVERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAbGlobeNewswireZURICH, SWITZERLAND, July 27, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA" or the ", Company", )), an emerging leader in designing novel cancer therapies, today announced the advancement of
- 3mo agoOABIOmniAb to Report Second Quarter 2026 Financial Results on August 6Business WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and
- 4mo agoOABIOmniAb Names Amechi Nwachuku Chief Operating OfficerBusiness WireOmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it has appointed Amechi Nwachuku to the newly-created
- 6mo agoOABIOmniAb Reports First Quarter 2026 Financial Results and Business HighlightsBusiness WireConference Call Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and
- 6mo agoOABIOmniAb to Participate in Three Upcoming Investor ConferencesBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in three investor conferences over the coming weeks. H.C. Wainwright 2nd Annual Royalty Company Virtual Conference, May 6. Management
- 6mo agoOABIOmniAb to Report First Quarter 2026 Financial Results on May 7Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on Thursday, May 7, 2026, and will hold a conference call that same day
- 8mo agoOABIOmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsBusiness WireConference Call Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner program
- 8mo agoOABIOmniAb to Participate at the Leerink Partners Global Healthcare ConferenceBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will participate at the Leerink Global Healthcare Conference taking place March 8-11, 2026, at the W South Beach in Miami. Management will present a corporate
- 8mo agoOABIOmniAb to Report Fourth Quarter 2025 Financial Results on March 4Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the quarter and year ended December 31, 2025, after the close of the U.S. financial markets on Wednesday, March 4, 2026, and will hold a conference call that
- 11mo agoOABILaunch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery TechnologiesBusiness WireFirst and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework broadens therapeutic opportunities beyond conventional antibodies OmniUltra Virtual Investor Event
- 11mo agoGTBPERASFHTXOABI+1Platform Technologies Drive $211B Surge in Precision Cancer TreatmentPR NewswireEquity Insider News Commentary – November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies...
- 11mo agoOABIOmniAb to Hold OmniUltra Virtual Investor Event on December 15Business WireOmniAb, Inc. (NASDAQ:OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on Monday, December 15, 2025, beginning at 5:00 p.m. Eastern time. The event is expected to
- 11mo agoOABIOmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global InvestorsBusiness WireAgreement is focused on OmnidAb™ single domain technology OmniAb to receive revenue for discovery services as well as potential equity and royalties OmniAb, Inc. (NASDAQ:OABI) and ArrowMark Partners
- 1y agoOABIOmniAb Reports Third Quarter 2025 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three and nine months ended September 30, 2025, and provided operating and partner
- 1y agoOABIOmniAb to Participate in Three Investor Conferences in NovemberBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in three investor conferences during the month of November. 2025 Truist Securities BioPharma Symposium, November 6 at the Lotte New
- 1y agoOABIOmniAb to Report Third Quarter 2025 Financial Results on November 4Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three and nine months ended September 30, 2025, after the close of the U.S. financial markets on Tuesday, November 4, 2025, and will hold a conference
- 1y agoOABIOmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment ConferenceBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will participate at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel.
- 1y agoOABIOmniAb, Inc. (OABI) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoOABIOmniAb Reports Second Quarter 2025 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three and six months ended June 30, 2025, and provided operating and partner
- 1y agoOABIOmniAb to Report Second Quarter 2025 Financial Results on August 6Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Wednesday, August 6, 2025, and will hold a conference call that
- 1y agoTEMOABITVGNRXRXAI Is Quietly Reinventing Healthcare--And Real Deployments Are Now UnderwayPR NewswireSeveral experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative AI apps demonstrating...
- 1y agoOABIOmniAb Reports First Quarter 2025 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program
- 1y agoOABIOmniAb Introduces the xPloration® Partner Access ProgramBusiness WireHigh-Throughput Single B-Cell Screening Platform Now Available for Purchase by OmniAb's Partners for Use in Their Own Laboratories OmniAb, Inc. (NASDAQ:OABI) today introduced the launch of the xPloration Partner Access
- 1y agoOABIVACHVERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramGlobeNewswireZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),
- 1y agoOABIOmniAb to Participate in Five Upcoming Investor ConferencesBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in five investor conferences over the coming weeks. H.C. Wainwright 1st Annual Royalty Company Virtual Conference, May 13. Management
- 1y agoCAPROABITECHOmniAb Announces Two New Appointments to its Board of DirectorsBusiness WirePhilip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.
- 1y agoOABIOmniAb to Report First Quarter 2025 Financial Results on May 8Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Thursday, May 8, 2025, and will hold a conference call that same day
- 1y agoOABIOmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three and 12 months ended December 31, 2024, and provided operating and partner
- 1y agoOABIOmniAb to Report Fourth Quarter 2024 Financial Results on March 18Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Tuesday, March 18, 2025 and will hold a conference call that
- 1y agoOABIOmniAb to Participate in Two Investor Conferences in MarchBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in two investor conferences during the month of March. TD Cowen 45th Annual Health Care Conference, March 3-5 at the Boston Marriott
- 1y agoOABIKuehn Law Encourages Investors of OmniAb, Inc. to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of OmniAb, Inc. (NASDAQ: OABI) breached...
- 1y agoOABIOmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics ConferenceBusiness WirePresentations included a case study of the workflow for building multispecifics and the launch of OmniHub™, a bioinformatics tools platform OmniAb, Inc. (NASDAQ:OABI) today announced that two presentations
- 1y agoOABIOmniAb, Inc. (OABI) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoOABIOmniAb Reports Third Quarter 2024 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner
- 2y agoOABIOmniAb to Participate in Two Investor Conferences in NovemberBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in two investor conferences during the month of November. Stifel 2024 Healthcare Conference, November 18-19 at the Lotte New York Palace
- 2y agoOABIOmniAb to Report Third Quarter 2024 Financial Results on November 12Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on Tuesday, November 12, 2024 and will hold a conference call
- 2y agoOABIOmniAb to Participate in Two Investor Conferences in SeptemberBusiness WireOmniAb, Inc. (NASDAQ:OABI) today announced that management will be participating in two investor conferences during the month of September. H.C. Wainwright 26th Annual Global Investment Conference, September 9-11 at
- 2y agoOABIOmniAb, Inc. (OABI) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOABIOmniAb Reports Second Quarter 2024 Financial Results and Business HighlightsBusiness WireConference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three and six months ended June 30, 2024, and provided operating and partner
- 2y agoOABIOmniAb to Report Second Quarter 2024 Financial Results on August 8Business WireOmniAb, Inc. (NASDAQ:OABI) will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Thursday, August 8, 2024 and will hold a conference call that